Annual Net Income
-$114.53 M
+$7.65 M+6.26%
December 31, 2022
Summary
- As of February 8, 2025, EVLO annual net profit is -$114.53 million, with the most recent change of +$7.65 million (+6.26%) on December 31, 2022.
- During the last 3 years, EVLO annual net income has fallen by -$29.05 million (-33.99%).
- EVLO annual net income is now -759.04% below its all-time high of -$13.33 million, reached on December 31, 2016.
Performance
EVLO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$12.36 M
+$8.74 M+41.41%
September 30, 2023
Summary
- As of February 8, 2025, EVLO quarterly net profit is -$12.36 million, with the most recent change of +$8.74 million (+41.41%) on September 30, 2023.
- Over the past year, EVLO quarterly net income has increased by +$18.20 million (+59.55%).
- EVLO quarterly net income is now -130.24% below its all-time high of -$5.37 million, reached on March 31, 2017.
Performance
EVLO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$82.35 M
+$18.20 M+18.10%
September 30, 2023
Summary
- As of February 8, 2025, EVLO TTM net profit is -$82.35 million, with the most recent change of +$18.20 million (+18.10%) on September 30, 2023.
- Over the past year, EVLO TTM net income has increased by +$37.29 million (+31.17%).
- EVLO TTM net income is now -1433.50% below its all-time high of -$5.37 million, reached on March 31, 2017.
Performance
EVLO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
EVLO Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.3% | +59.5% | +31.2% |
| 3 y3 years | -34.0% | +40.9% | +5.6% |
| 5 y5 years | -308.3% | +22.0% | +3.6% |
EVLO Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +6.3% | at high | +59.5% | at high | +33.5% |
| 5 y | 5-year | -34.0% | +6.3% | at high | +63.3% | at high | +33.5% |
| alltime | all time | -759.0% | +6.3% | -130.2% | +63.3% | -1433.5% | +33.5% |
Evelo Biosciences Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$12.36 M(-41.4%) | -$82.35 M(-18.1%) |
| Jun 2023 | - | -$21.10 M(-16.7%) | -$100.55 M(-8.6%) |
| Mar 2023 | - | -$25.34 M(+7.6%) | -$110.01 M(-3.9%) |
| Dec 2022 | -$114.53 M(-6.3%) | -$23.54 M(-23.0%) | -$114.53 M(-4.3%) |
| Sep 2022 | - | -$30.56 M(+0.0%) | -$119.64 M(-2.6%) |
| Jun 2022 | - | -$30.56 M(+2.3%) | -$122.80 M(-0.8%) |
| Mar 2022 | - | -$29.86 M(+4.2%) | -$123.84 M(+1.4%) |
| Dec 2021 | -$122.18 M(+30.4%) | -$28.65 M(-15.1%) | -$122.18 M(-0.3%) |
| Sep 2021 | - | -$33.73 M(+6.7%) | -$122.57 M(+11.7%) |
| Jun 2021 | - | -$31.60 M(+12.1%) | -$109.77 M(+11.1%) |
| Mar 2021 | - | -$28.20 M(-2.9%) | -$98.82 M(+5.5%) |
| Dec 2020 | -$93.67 M | -$29.05 M(+38.8%) | -$93.67 M(+7.4%) |
| Sep 2020 | - | -$20.92 M(+1.3%) | -$87.22 M(-0.8%) |
| Jun 2020 | - | -$20.65 M(-10.4%) | -$87.92 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$23.04 M(+2.0%) | -$88.21 M(+3.2%) |
| Dec 2019 | -$85.47 M(+50.1%) | -$22.60 M(+4.5%) | -$85.47 M(+9.1%) |
| Sep 2019 | - | -$21.63 M(+3.3%) | -$78.32 M(+8.0%) |
| Jun 2019 | - | -$20.94 M(+3.2%) | -$72.54 M(+8.7%) |
| Mar 2019 | - | -$20.30 M(+31.4%) | -$66.75 M(+17.2%) |
| Dec 2018 | -$56.95 M(+103.0%) | -$15.44 M(-2.6%) | -$56.95 M(+14.7%) |
| Sep 2018 | - | -$15.86 M(+4.7%) | -$49.65 M(+18.3%) |
| Jun 2018 | - | -$15.15 M(+44.2%) | -$41.96 M(+26.5%) |
| Mar 2018 | - | -$10.50 M(+28.9%) | -$33.18 M(+18.3%) |
| Dec 2017 | -$28.05 M(+110.4%) | -$8.14 M(-0.4%) | -$28.05 M(+40.9%) |
| Sep 2017 | - | -$8.17 M(+28.5%) | -$19.90 M(+69.7%) |
| Jun 2017 | - | -$6.36 M(+18.5%) | -$11.73 M(+118.5%) |
| Mar 2017 | - | -$5.37 M | -$5.37 M |
| Dec 2016 | -$13.33 M | - | - |
FAQ
- What is Evelo Biosciences annual net profit?
- What is the all time high annual net income for Evelo Biosciences?
- What is Evelo Biosciences annual net income year-on-year change?
- What is Evelo Biosciences quarterly net profit?
- What is the all time high quarterly net income for Evelo Biosciences?
- What is Evelo Biosciences quarterly net income year-on-year change?
- What is Evelo Biosciences TTM net profit?
- What is the all time high TTM net income for Evelo Biosciences?
- What is Evelo Biosciences TTM net income year-on-year change?
What is Evelo Biosciences annual net profit?
The current annual net income of EVLO is -$114.53 M
What is the all time high annual net income for Evelo Biosciences?
Evelo Biosciences all-time high annual net profit is -$13.33 M
What is Evelo Biosciences annual net income year-on-year change?
Over the past year, EVLO annual net profit has changed by +$7.65 M (+6.26%)
What is Evelo Biosciences quarterly net profit?
The current quarterly net income of EVLO is -$12.36 M
What is the all time high quarterly net income for Evelo Biosciences?
Evelo Biosciences all-time high quarterly net profit is -$5.37 M
What is Evelo Biosciences quarterly net income year-on-year change?
Over the past year, EVLO quarterly net profit has changed by +$18.20 M (+59.55%)
What is Evelo Biosciences TTM net profit?
The current TTM net income of EVLO is -$82.35 M
What is the all time high TTM net income for Evelo Biosciences?
Evelo Biosciences all-time high TTM net profit is -$5.37 M
What is Evelo Biosciences TTM net income year-on-year change?
Over the past year, EVLO TTM net profit has changed by +$37.29 M (+31.17%)